Connect with us

Technology

BIOSAPIEN – THE REVOLUTIONARY CANCER PLATFORM DEVELOPER – NOMINATED AS “BEST STARTUP” IN THE 2026 PRIX GALIEN USA AWARDS

Published

on

San Diego-based biotech pioneer shortlisted for the Prix Galien – having shown tremendous potential to improve human health

SAN DIEGO  , Aug. 14, 2026 /PRNewswire/ — BioSapien, the pioneering biotech company, is delighted to announce it has been nominated by The Galien Foundation – the premier global institution dedicated to honoring innovators in life sciences – in the “Best Startup” category, for the 20th Prix Galien USA Awards.

The Prix Galien USA Awards are widely regarded as one of the life sciences’ most prestigious recognitions of innovation, celebrating companies, and technologies with the potential to meaningfully advance human health. Nominees are selected by Awards Committees of leading biomedical scientists, industry executives and Nobel laureates; from thousands of applications. Awards Committee members for the “Best Startup” category come from companies such as: Merck; UCB; Pfizer; Johnson & Johnson; Janssen; Avon; Alexandria and Sanofi.

BioSapien’s nomination comes at a pivotal stage in the Company’s development, as its revolutionary cancer platform – MediChip™ – moves toward first-in-human dosing and BioSapien transitions from platform development into clinical validation.

Winners will be announced during the 20th Prix Galien USA Awards Ceremony on October 29th, 2026, at the American Museum of Natural History in New York City.

Dr. Khatija Ali, CEO and Founder of BioSapien, said:

“We are deeply honored that BioSapien has been nominated in the Best Startup category for the Prix Galien USA Awards. Science matters most when it touches lives, and our mission is to revolutionise how chemotherapy is delivered; to increase the quality of life during treatment and potentially prevent life-altering surgeries. We are proud to stand alongside the other great innovators in our category and all the clinical pioneers who have come before us.”

MediChip™ is a drug delivery, 3D-printed, slow-release delivery platform attachable to any tissue with minimal systemic side effects. Local delivery means more of the drug stays in the tumor microenvironment (i.e., where the tumor is located) to aid more efficient oncology, such as downsized tumors, alleviate symptoms and prevent potentially life-altering surgeries. Local delivery also requires fewer quantities of drugs to be used while maintaining safety.

BioSapien is initially developing its platform for clinical trials in colorectal cancer patients, with scope to branch out to other cancers (pancreatic, lung), and non-cancer indications. Colorectal cancer is the most common cancer in men, the third most common cancer in women after breast and thyroid cancer, and the third most common cancer in both men and women.

Further information

Bridges Communications

victoria@bridges-communications.com

Notes to Editors

About BioSapien

BioSapien is the pioneering biotech company behind MediChip™, a revolutionary localised cancer treatment platform, attachable to any tissue with minimal systemic side effects. Local delivery means more of the drug stays in the tumor microenvironment.

BioSapien is set to commence imminent Phase I clinical trials for MediChip™ in the UAE – concentrating initially on colorectal cancer patients.

About The Galien Foundation

The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve human health. Its vision is to serve as a catalyst for the development of the next generation of treatments and technologies that will transform medical practice and save lives.

Established in Paris in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien is widely regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

Today, the Prix Galien operates through 16 chapters spanning over 75 countries across Africa, the Americas, Asia, and Europe. Expansion is currently underway in China, Singapore, and Australia.

In 2025, the Foundation launched the inaugural Prix Galien Bridges Forum and Awards Ceremony at the Nobel Forum in Stockholm, spanning Northern and Southern Europe, Israel, and the Middle East, and the first-ever Patient Summit for Prix Galien USA, reinforcing its commitment to science without borders.

The Nobel Prize and the Prix Galien share a common birthplace in Paris, where Alfred Nobel signed his last will and testament in 1895. However, while the Nobel Prize in Physiology or Medicine recognizes up to three individuals for specific discoveries, the Prix Galien honors the collaborative spirit and multidisciplinary progress that define modern biopharmaceutical innovation.

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biosapien—the-revolutionary-cancer-platform-developer–nominated-as-best-startup-in-the-2026-prix-galien-usa-awards-302851949.html

SOURCE BioSapien Inc

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

VetsinTech Announces Finalists in Annual Tech Startup Pitch Competition 2026

Published

on

By

Veteran- and Military Spouse-Owned Startups Compete for $40,000 in Cash Prizes

SAN FRANCISCO, Aug. 14, 2026 /PRNewswire/ — VetsinTech, the leading national non-profit dedicated to supporting veterans through tech-based programs and opportunities in education, employment, and entrepreneurship, today announced the top finalists for its 2026 Startup Pitch Competition. In its 6th year, the competition continues to attract innovative ideas and high-caliber startups from veteran, military, and spouse-owned businesses. J.P. Morgan returns as the sponsor of the annual competition.

The five finalists advance to the final round of VetsinTech’s startup pitch competition, where they will compete live for cash prizes at Andreessen Horowitz’s San Francisco office on August 20, 2026. The winners will be announced during the in-person pitch event.

The veteran- and military spouse-owned advancing to the final round are:

Hardshell – Protects AI training and RAG data from poisoning, leakage, and manipulation. https://www.hardshell.ai/Hyperios Technologies – Physics-aware sensor fusion for space and missile threat detection. https://www.hyperios.com/Supply Veins – AI procurement platform that turns supplier emails into execution workflows. https://www.supplyveins.com/Phinorm – Software that improves drone detection and classification on existing sensors. https://www.phinorm.com/Bandelier Technologies – Quantum navigation and long-range detection for GPS-denied defense operations. https://www.bandeliertech.com/

Eligibility for the contest requires that each business be an early-stage startup founded by veterans or military spouses. The judges will evaluate each startup based on innovation, product-market fit, and potential impact, spanning market scalability and real benefit to the market. Cash prizes will be awarded to the top winners as follows:

1st place prize: $25,0002nd place prize: $10,0003rd place prize: $5,000

“Every year this competition reminds us how much veteran and military spouse founders bring to the table. This year’s finalists rose above a deep field, with each one addressing a real problem the market has overlooked. We’re proud to give veterans and military spouses the national stage they deserve and are thankful to J.P. Morgan for standing with these entrepreneurs as they build the companies that will define what comes next,” said Katherine Webster, Founder and CEO of VetsinTech.

About VetsinTech
Based in San Francisco with more than 125,000 veterans and 28 chapters across the country, VetsinTech is the leading national non-profit devoted 100% to springboarding veterans into tech careers. VetsinTech harnesses the national technology ecosystem to help veterans returning from active military duty pursue new technology careers by applying their exceptional training, skills, and experience. Comprising technology industry leaders and former service members, VetsinTech is the only non-profit supporting veterans and military spouses through tech-based education, employment, and entrepreneurship programs. Learn more at www.VetsinTech.co.

Press Contact:
Carmen Hughes
Ignite X
420787@email4pr.comn
650.576.6444

View original content to download multimedia:https://www.prnewswire.com/news-releases/vetsintech-announces-finalists-in-annual-tech-startup-pitch-competition-2026-302851954.html

SOURCE VetsinTech

Continue Reading

Technology

RemotePeople Completes 2026 SOC 2 Type II Audit Across Security, Availability, and Confidentiality

Published

on

By

The New York-headquartered global Employer of Record renews its SOC 2 Type II attestation for a full 12-month period, adding to its ISO 27001 and GDPR certifications and its recent A+ platform security rating from Astra Security.

NEW YORK, Aug. 14, 2026 /PRNewswire/ — RemotePeople, a global provider of Employer of Record (EOR), payroll, and recruitment services operating in more than 150 countries, today announced the successful completion of its 2026 SOC 2 Type II audit, covering the Security, Availability, and Confidentiality Trust Service Criteria. The independent examination was performed by INTERCERT CPA LLC in accordance with AICPA SSAE 21 attestation standards and covered a continuous 12-month observation period from May 31, 2025 to May 30, 2026.

Unlike a SOC 2 Type I report, which evaluates the design of controls at a single point in time, a Type II report evaluates whether those controls actually operated effectively over a sustained period — in this case, an entire year. The auditor issued a clean opinion, confirming that RemotePeople’s controls were both suitably designed and operating effectively throughout the period to achieve its service commitments and system requirements.

What the audit covered

The examination scope covered RemotePeople’s cloud-hosted platform, including the following Trust Service Criteria:

Security — protection of the system against unauthorized access, both physical and logical.Availability — the system is available for operation and use as committed or agreed.Confidentiality — information designated as confidential is protected as committed or agreed.

Many EOR and HR technology providers scope their SOC 2 examination to Security alone. Extending to Availability and Confidentiality reflects the reality of RemotePeople’s work: the platform runs payroll for employees in more than 150 countries and holds sensitive personal, tax, and banking data on behalf of thousands of organizations. Downtime and data disclosure both carry direct consequences for customers.

Layered assurance across independent frameworks

The 2026 SOC 2 Type II attestation is the third pillar of RemotePeople’s independent security assurance stack, joining its ISO 27001 certification, GDPR compliance program, and the A+ platform security rating recently awarded by Astra Security following an AI-augmented penetration test of app.remotepeople.com. Together, these attestations cover control design, sustained operating effectiveness, data protection, and offensive security testing — from independent third parties operating under different methodologies.

“Our customers trust us with contracts, payroll, tax IDs, and banking details for their people in more than 150 countries. That trust has to be earned every year, not claimed once. A SOC 2 Type II covering not just Security but also Availability and Confidentiality, alongside our ISO 27001 and our recent Astra A+ rating, is how we prove — with independent third parties — that the platform behind the promise is doing what we say it is.”

— Antoine Boquen, CEO of RemotePeople

The full SOC 2 Type II report is available to RemotePeople customers and qualified prospects under NDA through the company’s Trust Center at eu.sprinto.com/trust-center/view/0656f314-c72e-4fad-a251-258d8102fef8.

About RemotePeople

RemotePeople is a global Employer of Record (EOR), payroll, and recruitment provider headquartered in New York, helping companies hire, pay, and manage employees in 150+ countries without setting up a local entity. Its platform covers the full “recruit, employ, incorporate” journey: international recruitment through an in-house team, EOR, global payroll, benefits administration, Contractor of Record (COR), global mobility with work-visa sponsorship, US PEO, and company incorporation. RemotePeople is the trusted solution of more than 3,000 organizations, including Binance, Boeing, Coinbase, Porsche, LVMH, and Bang & Olufsen, and is certified SOC 2 Type II, GDPR, and ISO 27001. The company was named best Employer of Record platform in the G2 Summer 2026 reports, with 80+ badges, and ranked #1 in the 2026 best EOR guides published by People Managing People, SelectSoftwareReviews, and Outsource Accelerator. Learn more at remotepeople.com.

Press contact

RemotePeople
Pierre Pradier — Chief Marketing & Innovation Officer
pierre.pradier@remotepeople.com
remotepeople.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/remotepeople-completes-2026-soc-2-type-ii-audit-across-security-availability-and-confidentiality-302851965.html

Continue Reading

Technology

Michael Owen Joins ehamarkets as Global Brand Ambassador

Published

on

By

HONG KONG and NEW YORK, Aug. 14, 2026 /PRNewswire/ — ehamarkets today announced a global brand partnership with England football legend and 2001 Ballon d’Or winner Michael Owen, who has joined the brand as its Global Brand Ambassador.

Owen said he was drawn to ehamarkets’ focus on technology, reliability and a simpler trading experience.

“I’m delighted to join ehamarkets as its Global Brand Ambassador. I like the way ehamarkets uses technology to make trading simpler and more efficient. It’s exciting to be part of a brand that is building a modern trading experience for people around the world.”

Markus Weber, CEO of ehamarkets, said the partnership marks a new chapter for the company as it continues to grow its global presence and invest in trading technology.

“Michael Owen is one of the most recognizable names in English football, and we are proud to welcome him to ehamarkets. His career, achievements and international appeal make him a great fit for our global brand. This partnership is an important step as we continue to grow in markets around the world.

Our goal is simple: make advanced trading technology easier to use. We will keep investing in secure systems, smart technology and AI to make trading simpler, faster and more efficient. With ehamarkets AI, we are building a platform that helps traders navigate the markets with greater ease.”

ehamarkets is a global multi-asset trading platform offering access to forex, commodities, equities and indices. Its focus is to make trading simpler through advanced technology, stable systems and ehamarkets AI, an intelligent trading assistant that helps users monitor markets, receive real-time alerts and interact with trading tools through natural language.

In 2026, ehamarkets was named Best Mobile Trading Platform Global and Most Trusted Trading Platform Global.

A former Liverpool, Real Madrid, Newcastle United and Manchester United striker, Michael Owen made 89 appearances for England and won the 2001 Ballon d’Or.

Official Website >> https://www.ehamarkets.com/
Download the App >> https://go.onelink.me/Flyh?pid=prhome

Risk Disclaimer: This content is for informational purposes only. CFDs are leveraged products and carry a high level of risk, which may result in the loss of all invested capital.

SOURCE EHAMARKETS

Continue Reading

Trending